Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

NCT05555732 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1170

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Non Small Cell Lung Cancer

Interventions

DRUG: Datopotamab Deruxtecan
DRUG: Pembrolizumab
DRUG: Pemetrexed
DRUG: Carboplatin
DRUG: Cisplatin

Sponsor

Daiichi Sankyo

Collaborators

[object Object]
[object Object]